Alimera Sciences reported $7.64M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aerie Pharmaceuticals AERI:US $ -30.76M 0.92M
Applied Genetic Technologies AGTC:US $ -15.64M 2.66M
Bayer BAYN:GR € 2089M 946M
Insmed INSM:US $ -91545000 6.9M
Novartis NOVN:VX SF 4837M 65M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M